GloPID-R’s work highlighted in the latest IPPS Report

The International Pandemic Preparedness Secretariat (IPPS) has released its ‘100 Days Mission (100DM) Implementation Report: Progress in 2025 and Priorities for 2026’. Published on 27 January 2026, the independent report assesses global progress towards the 100 Days Mission and identifies priority actions for the year ahead. 

The 100 Days Mission was established to ensure that, in the event of a future pandemic, safe and effective diagnostics, therapeutics and vaccines can be developed, tested and made available within 100 days through rapid, coordinated action across science, policy and global collaboration. IPPS, a time-limited entity operating until March 2027, continues to monitor progress towards achieving these ambitious goals. 

While the report recognises the 100 Days Mission as a critical global ambition, it concludes that the 100-day target is not yet achievable across many areas. Significant gaps remain in diagnostics, therapeutics, vaccines, and in the systems required to deliver them at speed. The report therefore focuses on the distance the global community must still travel to fully realise the 100 Days Mission. 

GloPID-R’s contribution to pandemic preparedness 

The IPPS report highlights several of GloPID-R’s achievements to date, as well as its planned commitments and priority actions for 2026. In particular, the report recognises GloPID-R’s role in advancing the integration of global and regional clinical trials networks, and cites the launch of the Global Research Improving Pandemic Preparedness (GRIPP) initiative as an innovative and coordinated funding approach to strengthen preparedness. 

Through its Clinical Trials Working Group, GloPID-R has developed a monitoring, evaluation and learning framework to support its ‘Living Roadmap on Clinical Trial Coordination’ . This work includes mapping related investments and policy changes across the consortium to track progress, and was made publicly available in 2025. 

The report also references the GloPID-R Research and Policy Team’s updated scoping review, ‘Addressing challenges for clinical research responses to emerging epidemics and pandemics’, published in eClinical Medicine in June 2025. 

In addition, the Pandemic PACT Programme’s new 100 Days Mission data tracker, which tracks and visualises research investments aligned with the 100DM objectives is highlighted.